All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

Uso de heparinas de bajo peso molecular en el manejo ambulatorio de pacientes con trombosis venosa profunda. Estudio comparativo: heparina no fraccionada vs heparina de bajo peso molecular

Presentación de un caso: trombosis venosa profunda bilateral de etiología infrecuente Case report: rare bilateral deep venous thrombosis

Trombosis venosa profunda asociada a bacteriemia por campylobacter fetus Deep vein thrombosis related to Campylobacter fetus bacteriemia

Um toque de exercício: prevenindo a trombose venosa profunda GET EXERCISE: PREVENTING DEEP VEIN-THROMBOSIS UN TOQUE DE EJERCICIO: PREVINIENDO LA TROMBOSIS VENOSA PROFUNDA

TROMBOEMBOLISMO PULMONAR: VENOGRAFIA POR TOMOGRAFIA COMPUTADA VERSUS ECOGRAFíA DOPPLER, PARA DETECCION DE TROMBOSIS VENOSA PROFUNDA DE EXTREMIDADES INFERIORES

Heparinas de bajo peso molecular frente a heparinas no fraccionadas en el tratamiento de la trombosis venosa profunda

Trombosis venosa profunda

Caracterización clínica de la trombosis venosa profunda en enfermos con VIH/sida Clinic characterization of deep vein thrombosis in HIV/AIDS patients

Tratamiento de la trombosis venosa profunda con heparinas de bajo peso molecular: Estudio comparativo con anticoagulación oral

Trombosis venosa profunda en relación a un catéter central: Edema neonatal en esclavina, un caso clínico Deep vein thrombosis caused by central venous line and causing shoulder girdle oedema: a clinical case

More...

Tratamiento en domicilio de trombosis venosa profunda con heparinas de bajo peso molecular: Experiencia de un a?o

DOI: 10.4321/S0212-71992003000300005

Keywords: deep-vein trombosis, low-molecular-weight heparins, tinzaparin, home-care.

Full-Text   Cite this paper   Add to My Lib

Abstract:

treatment of patients with proximal vein thrombosis with low molecular weight heparins is effective and safe. so it allows "hospital at home" care. among low molecular weight heparins tinzaparin is given once daily, making the compliance easier. the twenty patients with deep vein thrombosis who were assisted in the "hospital at home" unit of the clínica nuestra se?ora de la concepción in madrid from december 1999 to december 2000. the mean of age was 71 + 15. the most frequent risk factors were surgery in past three months (19%), known tumour (15%) and previous venous thrombosis (15%). eighteen patients were treated with tinzaparin. no patients showed adverse effects nor complications. low molecular weight heparins, specially tinzaparin, are a safe and effective treatment for deep vein thrombosis in our unit.

Full-Text

comments powered by Disqus